MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Unusual presentation of POLR3A-associated leukodystrophy – two cases reported

N. Mazalica, A. Milovanovic, M. Sarcevic, A. Tomic, V. Markovic, M. Brankovic, A. Marjanovic, N. Dragasevic-Miskovic (Belgrade, Serbia)

Meeting: 2025 International Congress

Keywords: Ataxia: Clinical features, Dystonia: Clinical features, Hypokinesia

Category: Dystonia: Genetics

Objective: Presentation of two patients with different clinical manifestations of a POLR3A-related leukodystrophy (NM_007055.4)

Background: POLR3A related leukodystrophy is an autosomal recessive disease caused by mutation in the POLR3A gene that leads to the manifestation of neurological and non-neurological signs, and it is characterised by a typical pattern of hypomyelinating leukodystrophy on brain MRI.

Method: We present two patients with early-onset disease and clinical manifestations of generalised dystonia in one and parkinsonism in the other. Both patients underwent a comprehensive evaluation including neurological, neuropsychological and other non neurological examinations. Given the unclear aetiology of the disease, we performed genetic analysis by next-generation sequencing (TruSight One panel), which revealed the presence of a biallelic pathogenic variant in POLR3A (NM_007055.4): c.1771-6 C>G, while in the second patient two heterozygous pathological variants were detected: c.1771-6C>G; c.1771-7C>G in the POLR3A gene.

Results: In the first patient, the disease started with foot dystonia, which then developed into a generalised pattern of dystonia. In addition to dystonia, dystonic head tremor are present, as well as gait and limb ataxia. Accompanying neurological signs are cognitive impairment, while short stature is due to non-neurological signs without growth hormone abnormalities. Brain MRI showed T2 hyperintensity in the midbrain. In the second patient, the disease started with instability, while the neurological findings were slowness, hypokinesia, kinetic tremor and gait ataxia with normal brain MRI.

Conclusion: POLR3A related leukodystrophy can present with a wide spectrum of clinical features, ranging from generalised dystonia to parkinsonism without specific dental and endocrine abnormalities, even in the absence of a specific pattern of hypomyelination on brain MRI, broadening the spectrum of this disorder.

To cite this abstract in AMA style:

N. Mazalica, A. Milovanovic, M. Sarcevic, A. Tomic, V. Markovic, M. Brankovic, A. Marjanovic, N. Dragasevic-Miskovic. Unusual presentation of POLR3A-associated leukodystrophy – two cases reported [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/unusual-presentation-of-polr3a-associated-leukodystrophy-two-cases-reported/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/unusual-presentation-of-polr3a-associated-leukodystrophy-two-cases-reported/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley